SPY413.21+0.35 0.08%
DIA338.85+2.06 0.61%
IXIC13,964.38-31.72 -0.23%

BRIEF-Cabaletta Bio Reports Q4 2020 Financial Results

· 03/16/2021 07:40
BRIEF-Cabaletta Bio Reports Q4 2020 Financial Results

- Cabaletta Bio Inc CABA.O:

  • CABALETTA BIO - EXPECTS CASH AND CASH EQUIVALENTS & INVESTMENTS AS OF DEC 31, 2020 WILL ENABLE IT TO FUND OPERATING PLAN THROUGH AT LEAST Q3 OF 2022

  • CABALETTA BIO INC QTRLY NET LOSS PER VOTING AND NON-VOTING SHARE, BASIC AND DILUTED $0.40

Source text for Eikon: ID:nGNX8gtBpD

Further company coverage: CABA.O


((Reuters.Briefs@thomsonreuters.com;))